TrialJournal of the American Heart Association2024

Safety, Tolerability, and Pharmacodynamics of AZD3366 (Optimized Human CD39L3 Apyrase) Alone and in Combination With Ticagrelor and Acetylsalicylic Acid: A Phase 1, Randomized, Placebo-Controlled Study.

Dimitris Kardassis et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.